From The News & Observer
By Brian Wittee
June 30, 2019
EXCERPT
In a separate new Maryland law, the state will be able to create a review board on prescription drug costs. The five board members haven’t been named yet. Supporters say the law is a step toward creating an independent board with the authority to evaluate expensive drugs and recommend methods for addressing high costs.
The board will be able to set upper-payment limits on prescription drug costs for state and local governments, with approval from a legislative panel in 2022.
Last modified: June 30, 2019
